Team Startupcity

·  W Health Ventures launches $70M Fund II to build 8–10 India-focused healthtech startups.

·  Backs ventures from scratch via its studio model with 2070 Health, not traditional funding.

·  First investment: EverHope Oncology, in partnership with Narayana Health, for cancer care.

 W Health Ventures, the healthcare-focused venture capital firm founded by Sunil Wadhwani, has officially launched its second fund targeting $70 million (approximately  Rs 610 crore), with a possible hard cap up to $100 million ( Rs 850 crore).

Breaking away from conventional VC investing, W Health adopts a "company creation" approach. Rather than investing in outside startups, the company co-creates fresh healthcare businesses in collaboration with the venture studio 2070 Health. Fund II will incubate 8–10 new businesses over four years, with early-stage investments of $3–5 million for each business and overall commitments of $5–10 million per venture.

Also Read- NSDL Raises Rs 1,200 Crore from Anchor Investors Ahead of IPO Opening

Fund II will focus on two main themes:

- Single-specialty care delivery platforms intended for filling clinical white spaces in India.

- AI-powered B2B healthcare service providers serving clients both in India and in the U.S.–India market.

W Health has already invested capital from its most recent fund its first announced investment is EverHope Oncology, established in collaboration with Narayana Health, with a purpose of enhancing cancer care delivery through outpatient centers in India with international standards.

With its previous fund (~$50 million), W Health supported startups like Mylo (parenting), BeatO (diabetes), Nivaan Care (chronic pain), and Wysa (AI‑driven mental health) reaching more than 25 million users globally.

Managing Partner Pankaj Jethwani referenced the strong growth in India's healthcare expenditures increase of 15–20% per year and stressed the long-term potential in growing access and high-quality care. He said AI and technology are facilitators, but combined physical and clinical operations continue to be essential in tertiary care and models of chronic disease.

With this second fund, W Health Ventures will amplify category-winning healthcare startups using capital, clinical networks, and founder support to fill unmet needs and bring measurable impact to domestic and international markets.